352 related articles for article (PubMed ID: 26279012)
61. Development of 3D dynamic flow model of human liver and its application to prediction of metabolic clearance of 7-ethoxycoumarin.
Choi K; Pfund WP; Andersen ME; Thomas RS; Clewell HJ; LeCluyse EL
Tissue Eng Part C Methods; 2014 Aug; 20(8):641-51. PubMed ID: 24294911
[TBL] [Abstract][Full Text] [Related]
62. Use of bioreactors in maxillofacial tissue engineering.
Depprich R; Handschel J; Wiesmann HP; Jäsche-Meyer J; Meyer U
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):349-54. PubMed ID: 18343545
[TBL] [Abstract][Full Text] [Related]
63. Neuromuscular disease modeling on a chip.
Santoso JW; McCain ML
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32817118
[TBL] [Abstract][Full Text] [Related]
64. A 3D microfluidic platform incorporating methacrylated gelatin hydrogels to study physiological cardiovascular cell-cell interactions.
Chen MB; Srigunapalan S; Wheeler AR; Simmons CA
Lab Chip; 2013 Jul; 13(13):2591-8. PubMed ID: 23525275
[TBL] [Abstract][Full Text] [Related]
65. Controlling tissue microenvironments: biomimetics, transport phenomena, and reacting systems.
Fisher RJ; Peattie RA
Adv Biochem Eng Biotechnol; 2007; 103():1-73. PubMed ID: 17195461
[TBL] [Abstract][Full Text] [Related]
66. Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening.
Ahn J; Ko J; Lee S; Yu J; Kim Y; Jeon NL
Adv Drug Deliv Rev; 2018 Mar; 128():29-53. PubMed ID: 29626551
[TBL] [Abstract][Full Text] [Related]
67. Reconstitution of hepatic tissue architectures from fetal liver cells obtained from a three-dimensional culture with a rotating wall vessel bioreactor.
Ishikawa M; Sekine K; Okamura A; Zheng YW; Ueno Y; Koike N; Tanaka J; Taniguchi H
J Biosci Bioeng; 2011 Jun; 111(6):711-8. PubMed ID: 21402492
[TBL] [Abstract][Full Text] [Related]
68. The application of an optically switched dielectrophoretic (ODEP) force for the manipulation and assembly of cell-encapsulating alginate microbeads in a microfluidic perfusion cell culture system for bottom-up tissue engineering.
Lin YH; Yang YW; Chen YD; Wang SS; Chang YH; Wu MH
Lab Chip; 2012 Mar; 12(6):1164-73. PubMed ID: 22322420
[TBL] [Abstract][Full Text] [Related]
69. Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment.
Tsai HF; Trubelja A; Shen AQ; Bao G
J R Soc Interface; 2017 Jun; 14(131):. PubMed ID: 28637915
[TBL] [Abstract][Full Text] [Related]
70. Design and prototyping of a chip-based multi-micro-organoid culture system for substance testing, predictive to human (substance) exposure.
Sonntag F; Schilling N; Mader K; Gruchow M; Klotzbach U; Lindner G; Horland R; Wagner I; Lauster R; Howitz S; Hoffmann S; Marx U
J Biotechnol; 2010 Jul; 148(1):70-5. PubMed ID: 20138930
[TBL] [Abstract][Full Text] [Related]
71. Three-dimensional in vitro cancer models: a short review.
Wang C; Tang Z; Zhao Y; Yao R; Li L; Sun W
Biofabrication; 2014 Jun; 6(2):022001. PubMed ID: 24727833
[TBL] [Abstract][Full Text] [Related]
72. The three-dimensional cultivation of the carcinoma cell line HepG2 in a perfused chip system leads to a more differentiated phenotype of the cells compared to monolayer culture.
Altmann B; Giselbrecht S; Weibezahn KF; Welle A; Gottwald E
Biomed Mater; 2008 Sep; 3(3):034120. PubMed ID: 18765895
[TBL] [Abstract][Full Text] [Related]
73. On-Chip Construction of Liver Lobule-like Microtissue and Its Application for Adverse Drug Reaction Assay.
Ma C; Zhao L; Zhou EM; Xu J; Shen S; Wang J
Anal Chem; 2016 Feb; 88(3):1719-27. PubMed ID: 26743823
[TBL] [Abstract][Full Text] [Related]
74. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities.
Lan SF; Starly B
Toxicol Appl Pharmacol; 2011 Oct; 256(1):62-72. PubMed ID: 21839104
[TBL] [Abstract][Full Text] [Related]
75. Organ-on-chip models: Implications in drug discovery and clinical applications.
Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
[TBL] [Abstract][Full Text] [Related]
76. Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes.
Leclerc E; Sakai Y; Fujii T
Biotechnol Prog; 2004; 20(3):750-5. PubMed ID: 15176878
[TBL] [Abstract][Full Text] [Related]
77. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
Loessner D; Holzapfel BM; Clements JA
Adv Drug Deliv Rev; 2014 Dec; 79-80():193-213. PubMed ID: 24969478
[TBL] [Abstract][Full Text] [Related]
78. [Tissue engineering-based approaches to enhance physiological relevancy of cell-based assays].
Sakai Y; Shinohara M
Nihon Yakurigaku Zasshi; 2018; 151(2):56-61. PubMed ID: 29415926
[TBL] [Abstract][Full Text] [Related]
79. Recent advances and future applications of microfluidic live-cell microarrays.
Rothbauer M; Wartmann D; Charwat V; Ertl P
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):948-61. PubMed ID: 26133396
[TBL] [Abstract][Full Text] [Related]
80. Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels.
Malinen MM; Kanninen LK; Corlu A; Isoniemi HM; Lou YR; Yliperttula ML; Urtti AO
Biomaterials; 2014 Jun; 35(19):5110-21. PubMed ID: 24698520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
